Preliminary Results for the Year Ended 31 December 2001
Post navigation
←
Colostrinin™ continues trends towards efficacy in latest Interim findings from Clinical trial
ReGen Therapeutics successfully completes Interim funding round
→
Home
About Us
Our History
Directors
Products & Research
Colostrinin as a nutraceutical
Pharmaceuticals – Peptides
Pharmaceuticals – Zolpidem
Presentations
News
Announcements
Events Calendar
Email News Alerts
Contact Us